INtensity of OVarian Stimualtion and Euploid Embryos
Conditions: Fertility Interventions: Drug: Follitropin-delta (Rekovelle) 20 mcg/day from D1; Drug: Follitropin-delta (Rekovelle) 15 mcg/day from D1 Sponsors: Fundaci ón Santiago Dexeus Font Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials
HRD Tests for Ovarian cancER
Conditions: Ovarian Cancer Interventions: Genetic: tests to determine HRD status Sponsors: Centre Francois Baclesse Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials
Comparing the Safety and Efficacy in the Use of Hormonal Therapy on Endometriosis Patients After Conservative Surgery
Conditions: Endometriosis Ovary Interventions: Drug: Dienogest; Drug: Depo Medroxyprogesterone acetate; Drug: Leuprolide (as Leuprolide Acetate); Drug: Levonogestrel + etinilestradiol (30 mcg, brand name Mycrogynon) Sponsors: Universitas Diponegoro Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials
The Effectiveness of an Online Support Group in Enhancing Recovery Identity and Health-Related Quality of Life
Conditions: Ovarian Cancer Interventions: Behavioral: mobile online support group (experiment group); Behavioral: offline support group (control group) Sponsors: Shanghai Jiao Tong University School of Medicine Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for PCOS
Conditions: Polycystic Ovary Syndrome (PCOS); Polycystic Ovary Syndrome; PCOS Interventions: Biological: AlloRx Sponsors: The Foundation for Orthopaedics and Regenerative Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
Evaluation on Biological Characteristics of Acupoints in Premature Ovarian Insufficiency
Conditions: Premature Ovarian Insufficiency Interventions: Device: all patients and healthy people will receive at least 3 infrared thermal imaging examinations of acupoints and pain threshold examinations of acupoints. Sponsors: Xiaomei Shao Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome
Conditions: Poly Cystic Ovary Syndrome Interventions: Drug: Metformin Hydrochloride tablet; Drug: Vildagliptin 50 MG Sponsors: October 6 University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
The Effect of Dual Trigger (GnRH Agonist + hCG) for Final Maturation in Oocyte Donors With History of a Previous Cycle With Suboptimal Response to GnRH Agonist Only Trigger
Conditions: Ovarian Stimulation; Human Chorionic Gonadotropin; Oocyte Donors Interventions: Drug: Dual trigger (human chorionic gonadotropin plus GnRH-agonist); Drug: GnRH-agonist only trigger Sponsors: Embryolab Fertility Clinic; ART Fertility Clinics LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
Niraparib Maintenance in HRD-Positive Advanced Ovarian Cancer Following Front-Line Chemotherapy + Bevacizumab
Conditions: Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma Interventions: Drug: Niraparib Sponsors: Peking University Cancer Hospital& Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
Empagliflozin vs Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome.
Conditions: Polycystic Ovary Syndrome; Weight Gain; HbA1c Interventions: Drug: Empagliflozin 10 MG; Drug: MetFORMIN 500 Mg Oral Tablet Sponsors: SINA Health Education and Welfare Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials
Combined Program of Supervised Physical Exercise and Nutritional Counseling in Ovarian Cancer Patients on Frontline Maintenance Treatment With PARP Inhibitors
Conditions: Ovarian Cancer Interventions: Procedure: Exercise and dietary recommendations Sponsors: Oncare Madrid; Apices Soluciones S.L. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials
A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors
Conditions: Triple Negative Breast Cancer; High Grade Serous Ovarian Cancer; Endometrial Cancer Interventions: Drug: AO-252 Sponsors: A2A Pharmaceuticals Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
Autologous ADMSC Transplantation in Patients With POI
Conditions: Premature Ovarian Failure Interventions: Biological: stem cell therapy Sponsors: Mongolian National University of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials
Transforming Ovarian Cancer Diagnostic Pathways
Conditions: Ovarian Cancer Sponsors: Professor Sudha Sundar; University of Birmingham Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
The Registry of Genetic Alterations of Taiwan Ovarian Cancer
Conditions: Ovarian Cancer Sponsors: National Health Research Institutes, Taiwan; National Taiwan University Hospital; Mackay Memorial Hospital; Cathay General Hospital; China Medical University Hospital; Taichung Veterans General Hospital; National Cheng-Kung University Hospital; Chang Gung Medical Foundation; Kaohsiung Veterans General Hospital. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
